David F Hale - Net Worth and Insider Trading
David F Hale Net Worth
The estimated net worth of David F Hale is at least $103,890 dollars as of 2024-11-29. David F Hale is the Director of Conatus Pharmaceuticals Inc and owns about 143,739 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $80,494. David F Hale is the Director of Oncternal Therapeutics Inc and owns about 31,304 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $23,397. David F Hale is also the Director of Biocept Inc and owns about 134 shares of Biocept Inc (BIOCQ) stock worth over $0. Details can be seen in David F Hale's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David F Hale has not made any transactions after 2024-02-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David F Hale
David F Hale Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David F Hale owns 5 companies in total, including Biocept Inc (BIOCQ) , Oncternal Therapeutics Inc (ONCT) , and Histogen Inc (HSTO) among others .
Click here to see the complete history of David F Hale’s form 4 insider trades.
Insider Ownership Summary of David F Hale
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BIOCQ | Biocept Inc | 2021-12-09 | director & EXECUTIVE CHAIRMAN |
| ONCT | Oncternal Therapeutics Inc | 2024-02-23 | director |
| HSTO | Histogen Inc | 2013-07-24 | director |
 | | 2009-06-23 | director |
| | 2021-08-12 | director |
David F Hale Latest Holdings Summary
David F Hale currently owns a total of 3 stocks. Among these stocks, David F Hale owns 143,739 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $80,494 and a weighting of 77.48%. David F Hale owns 31,304 shares of Oncternal Therapeutics Inc (ONCT) as of February 23, 2024, with a value of $23,397 and a weighting of 22.52%. David F Hale also owns 134 shares of Biocept Inc (BIOCQ) as of December 9, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of David F Hale
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 143,739 | 0.56 | 80,494 |
| ONCT | Oncternal Therapeutics Inc | 2024-02-23 | 31,304 | 0.75 | 23,397 |
| BIOCQ | Biocept Inc | 2021-12-09 | 134 | 0.00 | 0 |
Holding Weightings of David F Hale
David F Hale Form 4 Trading Tracker
According to the SEC Form 4 filings, David F Hale has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the acquisition of 2,588 shares on July 30, 2013, which cost David F Hale around $28,468.
According to the SEC Form 4 filings, David F Hale has made a total of 1 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 980 shares on February 23, 2024, which cost David F Hale around $8,859.
According to the SEC Form 4 filings, David F Hale has made a total of 2 transactions in Biocept Inc (BIOCQ) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Biocept Inc is the sale of 15 shares on December 9, 2021, which brought David F Hale around $1,807.
Insider Trading History of David F Hale
- 1
David F Hale Trading Performance
GuruFocus tracks the stock performance after each of David F Hale's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David F Hale is 11.02%. GuruFocus also compares David F Hale's trading performance to market benchmark return within the same time period. The performance of stocks bought by David F Hale within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David F Hale's insider trading performs compared to the benchmark.
Performance of David F Hale
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.91 | | | | | |
| Relative Return to S&P 500(%) | -13.86 | | | | | |
David F Hale Ownership Network
David F Hale Owned Company Details
What does Biocept Inc do?
Who are the key executives at Biocept Inc?
David F Hale is the director & EXECUTIVE CHAIRMAN of Biocept Inc. Other key executives at Biocept Inc include VP & Controller Robert Walsh , Chief Operations Officer Philippe Marchand , and Sr. V.P. & General Counsel Darrell Taylor .
Biocept Inc (BIOCQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biocept Inc (BIOCQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biocept Inc (BIOCQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biocept Inc (BIOCQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biocept Inc Insider Transactions
David F Hale Mailing Address
Above is the net worth, insider trading, and ownership report for David F Hale. You might contact David F Hale via mailing address: 1042-b North El Camino Real, Suite 430, Encinitas Ca 92024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
